| JXSS2000030 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-07-24 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd;Catalent Indiana LLC;Astrazeneca Uk Ltd | Certificate Issued | 2021-07-15 | view |
| JXSL1500002 | MEDI4736 | durvalumab | Injection | Biological Products | Import Drug Application | 2015-02-11 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd;Medimmune LLC | Certificate Issued | 2016-08-25 | view |
| JXSS2000029 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-07-24 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd;Catalent Indiana LLC;Astrazeneca Uk Ltd | Certificate Issued | 2021-07-15 | view |
| JYSB2000599 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-12-03 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd;Catalent Indiana LLC;Astrazeneca Uk Ltd | Approval Completed-Pending Certificated | 2021-08-20 | view |
| JXSL1500041 | MEDI4736 | durvalumab | Injection | Biological Products | Import Drug Application | 2015-08-12 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd;Medimmune LLC | Certificate Issued | 2016-08-25 | view |
| JXSL1500045 | MEDI4736 | durvalumab | Injection | Biological Products | Import Drug Application | 2015-08-12 | 丘以思（上海）医药信息咨询有限公司 | Choice Pharma Medical Information Consultancy (Shanghai) Co Ltd;Medimmune LLC | Certificate Issued | 2016-08-08 | view |
| JYSB2000221 | MEDI4736 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-06-13 | 丘以思（上海）医药信息咨询有限公司 | Choice Pharma Medical Information Consultancy (Shanghai) Co Ltd;Medimmune LLC;MedImmune Pharma BV | In Review | 2020-06-12 | view |
| JXSL1500066 | MEDI4736 | durvalumab | Injection | Biological Products | Import Drug Application | 2015-11-26 | MedImmune LLC | Medimmune LLC | Certificate Issued | 2016-09-29 | view |
| JXSL1700012 | MEDI4736 | durvalumab | Injection | Biological Products | Import Drug Application | 2017-03-15 | MedImmune LLC | Medimmune LLC | Certificate Issued | 2017-08-22 | view |
| JXSL1600013 | MEDI4736 | durvalumab | Injection | Biological Products | Import Drug Application | 2016-03-14 | MedImmune LLC | Medimmune LLC | Certificate Issued | 2016-11-09 | view |
| JXSL2000019 | Durvalumab | durvalumab | Injection | Biological Products | Import Drug Application | 2020-02-19 | MedImmune LLC | Medimmune LLC | In Review | 2020-02-18 | view |
| JXSL1500062 | MEDI4736 | durvalumab | Injection | Biological Products | Import Drug Application | 2015-11-26 | MedImmune LLC | Medimmune LLC | Certificate Issued | 2017-01-03 | view |
| JXSL1500072 | MEDI4736 | durvalumab | Injection | Biological Products | Import Drug Application | 2015-12-11 | MedImmune LLC | Medimmune LLC | Certificate Issued | 2016-11-08 | view |
| JXSL1700053 | Durvalumab | durvalumab | Injection | Biological Products | Import Drug Application | 2017-09-13 | MedImmune LLC | Medimmune LLC | Certificate Issued | 2018-01-23 | view |
| JXSL1500064 | MEDI4736 | durvalumab | Injection | Biological Products | Import Drug Application | 2015-11-26 | MedImmune LLC | Medimmune LLC | Certificate Issued | 2016-08-25 | view |
| JXSL1700026 | Durvalumab | durvalumab | Injection | Biological Products | Import Drug Application | 2017-05-31 | MedImmune LLC | Medimmune LLC | Certificate Issued | 2017-10-27 | view |
| JXSL2000026 | Durvalumab | durvalumab | Injection | Biological Products | Import Drug Application | 2020-03-06 | | Medimmune LLC | In Review | 2020-03-05 | view |
| JXSS2300077 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-09-08 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSS2500037 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-03-28 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYSB2200078 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-04-24 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
